By Josh White
Date: Tuesday 20 Jan 2026
(Sharecast News) - Niox Group reported a strong financial performance for 2025 on Tuesday, with revenue and earnings ahead of market expectations, as the medical device group benefited from robust demand across its clinical and research businesses and successfully launched its next-generation Niox PRO device.
| Midwich ends year in line with expectations | 20-Jan-2026 | ShareCast |
| Craneware pleased with first-half performance | 20-Jan-2026 | ShareCast |
| Big Technologies reaches full and final settleme... | 19-Jan-2026 | ShareCast |
| SigmaRoc flags better-than-expected full-year pe... | 19-Jan-2026 | ShareCast |
| Nowicki takes over chairman at ITM Power | 16-Jan-2026 | ShareCast |
| Form 8.3 - IDOX plc - Octopus Investments | 20-Jan-2026 | 14:46 | GlobeNewswire NA |
| Director/PDMR Shareholding | 20-Jan-2026 | 13:45 | RNS |
| Form 8.5 (EPT/RI) - Idox PLC | 20-Jan-2026 | 12:00 | RNS |
| Form 8.3 - [IDOX PLC - 19 01 2026] - (CGWL) | 20-Jan-2026 | 09:05 | GlobeNewswire NA |
| Notice of Interim Results | 20-Jan-2026 | 07:00 | RNS |
| Questor :Quindell | 10-Dec-2014 | Telegraph |
| Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
| Questor :Asos | 23-Oct-2014 | Telegraph |
| Questor:Monitise PLC | 19-Sep-2014 | Telegraph |
| Questor:ASOS | 18-Sep-2014 | Telegraph |
| Price | 4,012.82 |
| Change Today | -28.31 |
| % Change | -0.70 % |
| 20-Jan-26 Close | 4,012.82 |
You are here: research